• 31682 Citations
1984 …2027
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1984 2019

Filter
Article
2012
40 Citations (Scopus)

Barriers to the use of personalized medicine in breast cancer

Weldon, C. B., Trosman, J. R., Gradishar, W. J., Benson III, A. B. & Schink, J. C., Jul 1 2012, In : Journal of Oncology Practice. 8, 4

Research output: Contribution to journalArticle

Precision Medicine
Breast Neoplasms
Molecular Pathology
Transcriptome
Insurance Carriers
7 Citations (Scopus)

Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: The National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI)

Butt, Z., Parikh, N. D., Beaumont, J. L., Rosenbloom, S. K., Syrjala, K. L., Abernethy, A. P., Benson III, A. B. & Cella, D., Dec 1 2012, In : Cancer. 118, 23, p. 5997-6004 8 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Neoplasms
Therapeutics
Bile Duct Neoplasms
Physicians
78 Citations (Scopus)
Colonic Neoplasms
Recurrence
Survival
Neoplasms
Disease-Free Survival
40 Citations (Scopus)
Hepatocellular Carcinoma
Neoplasm Metastasis
Blood Vessels
Therapeutics
Multivariate Analysis
133 Citations (Scopus)

Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704 - A phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas

Abrams, R. A., Winter, K. A., Regine, W. F., Safran, H., Hoffman, J. P., Lustig, R., Konski, A. A., Benson III, A. B., MacDonald, J. S., Rich, T. A. & Willett, C. G., Feb 1 2012, In : International Journal of Radiation Oncology Biology Physics. 82, 2, p. 809-816 8 p.

Research output: Contribution to journalArticle

Adjuvant Chemoradiotherapy
gemcitabine
pancreas
chemotherapy
Adjuvant Chemotherapy
21 Citations (Scopus)

Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial

Berger, A. C., Winter, K., Hoffman, J. P., Regine, W. F., Abrams, R. A., Safran, H., Freedman, G. M., Benson III, A. B., MacDonald, J. & Willett, C. G., Nov 1 2012, In : International Journal of Radiation Oncology Biology Physics. 84, 3

Research output: Contribution to journalArticle

Radiation Oncology
gemcitabine
radiation therapy
Radiotherapy
Survival
226 Citations (Scopus)
Radiation Oncology
Colostomy
Mitomycin
Fluorouracil
Cisplatin
9 Citations (Scopus)
irinotecan
Maximum Tolerated Dose
Diarrhea
Nausea
Capecitabine
2 Citations (Scopus)
Colonic Neoplasms
Adjuvant Chemotherapy
Recurrence
Risk Reduction Behavior
Morbidity
190 Citations (Scopus)

Predictive and prognostic roles of BRAF mutation in stage III colon cancer: Results from intergroup trial CALGB 89803

Ogino, S., Shima, K., Meyerhardt, J. A., McCleary, N. J., Ng, K., Hollis, D., Saltz, L. B., Mayer, R. J., Schaefer, P., Whittom, R., Hantel, A., Benson III, A. B., Spiegelman, D., Goldberg, R. M., Bertagnolli, M. M. & Fuchs, C. S., Feb 1 2012, In : Clinical Cancer Research. 18, 3, p. 890-900 11 p.

Research output: Contribution to journalArticle

Microsatellite Instability
Colonic Neoplasms
irinotecan
Mutation
Leucovorin
76 Citations (Scopus)
metastasis
liver
safety
Neoplasm Metastasis
Safety
2011
Rectal Neoplasms
Therapeutics
2 Citations (Scopus)
Neoplasm Staging
Adjuvant Chemotherapy
Tumor Biomarkers
Antineoplastic Agents
Biomedical Research
25 Citations (Scopus)
Digestive System Surgical Procedures
Antineoplastic Combined Chemotherapy Protocols
Maintenance Chemotherapy
Combined Modality Therapy
Neoadjuvant Therapy
40 Citations (Scopus)

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: Results from CALGB 9581

Niedzwiecki, D., Bertagnolli, M. M., Warren, R. S., Compton, C. C., Kemeny, N. E., Benson, A. B., Eckhardt, S. G., Alberts, S., Porjosh, G. N., Kerr, D. J., Anthony, Fields, Rougier, P., Pipas, J. M., Schwartz, J. H., Atkins, J., O'Rourke, M., Perry, M. C., Goldberg, R. M., Mayer, R. J. & 1 othersColacchio, T. A., Aug 10 2011, In : Journal of Clinical Oncology. 29, 23, p. 3146-3152 7 p.

Research output: Contribution to journalArticle

Natural History
Colon
Adenocarcinoma
Observation
Survival
167 Citations (Scopus)

Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. intergroup/RTOG 9704 phase III trial

Regine, W. F., Winter, K. A., Abrams, R., Safran, H., Hoffman, J. P., Konski, A., Benson III, A. B., MacDonald, J. S., Rich, T. A. & Willett, C. G., May 1 2011, In : Annals of surgical oncology. 18, 5, p. 1319-1326 8 p.

Research output: Contribution to journalArticle

gemcitabine
Fluorouracil
Adenocarcinoma
Drug Therapy
Survival
438 Citations (Scopus)

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial

Loehrer, P. J., Feng, Y., Cardenes, H., Wagner, L., Brell, J. M., Cella, D., Flynn, P., Ramanathan, R. K., Crane, C. H., Alberts, S. R. & Benson III, A. B., Nov 1 2011, In : Journal of Clinical Oncology. 29, 31, p. 4105-4112 8 p.

Research output: Contribution to journalArticle

gemcitabine
Pancreatic Neoplasms
Radiotherapy
Quality of Life
Survival
23 Citations (Scopus)

Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: A retrospective cohort study of the Eastern Cooperative Oncology Group

Yoon, H. H., Catalano, P. J., Murphy, K. M., Skaar, T. C., Philips, S., Powell, M., Montgomery, E. A., Hafez, M. J., Offer, S. M., Liu, G., Meltzer, S. J., Wu, X., Forastiere, A. A., Benson III, A. B., Kleinberg, L. R. & Gibson, M. K., May 17 2011, In : BMC cancer. 11, 176.

Research output: Contribution to journalArticle

Chemoradiotherapy
DNA Repair
Single Nucleotide Polymorphism
Adenocarcinoma
Cohort Studies
8 Citations (Scopus)
Oncology
Chemoradiotherapy
Platinum
Cisplatin
Toxicity
18 Citations (Scopus)
Anus Neoplasms
Fluorouracil
Cisplatin
cancer
Radiation
3 Citations (Scopus)
docetaxel
Carboplatin
Esophagus
Squamous Cell Carcinoma
Neutropenia
35 Citations (Scopus)
gemcitabine
Conformal Radiotherapy
Pancreatic Neoplasms
radiation therapy
cancer
84 Citations (Scopus)

Radiation segmentectomy: A novel approach to increase safety and efficacy of radioembolization

Riaz, A., Gates, V. L., Atassi, B., Lewandowski, R. J., Mulcahy, M. F., Ryu, R. K., Sato, K. T., Baker, T., Kulik, L., Gupta, R., Abecassis, M., Benson, A. B., Omary, R., Millender, L., Kennedy, A. & Salem, R., Jan 1 2011, In : International Journal of Radiation Oncology Biology Physics. 79, 1, p. 163-171 9 p.

Research output: Contribution to journalArticle

Segmental Mastectomy
safety
Radiation
Safety
dosage
368 Citations (Scopus)
Hepatocellular Carcinoma
Yttrium
Survival
Therapeutics
Standard of Care
104 Citations (Scopus)

Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times

Memon, K., Kulik, L., Lewandowski, R. J., Wang, E., Riaz, A., Ryu, R. K., Sato, K. T., Marshall, K., Gupta, R., Nikolaidis, P., Miller, F. H., Yaghmai, V., Senthilnathan, S., Baker, T., Gates, V. L., Abecassis, M., Benson, A. B., Mulcahy, M. F., Omary, R. A. & Salem, R., Jan 1 2011, In : Gastroenterology. 141, 2

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Survival
Liver
Therapeutics
Venous Thrombosis
47 Citations (Scopus)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Colonic Neoplasms
Recurrence
Survival
Disease-Free Survival
104 Citations (Scopus)
Hepatocellular Carcinoma
Guidelines
Liver
ROC Curve
Necrosis
75 Citations (Scopus)
Gastrointestinal Neoplasms
Medical Oncology
Stomach Neoplasms
Expert Testimony
Clinical Trials
47 Citations (Scopus)
Radiation Oncology
lymphatic system
Pancreatic Neoplasms
Disease-Free Survival
radiation therapy
2010
213 Citations (Scopus)

90Y-edotreotide for metastatic carcinoid refractory to octreotide

Bushnell, D. L., O'Dorisio, T. M., O'Dorisio, M. S., Menda, Y., Hicks, R. J., Van Cutsem, E., Baulieu, J. L., Borson-Chazot, F., Anthony, L., Benson, A. B., Oberg, K., Grossman, A. B., Connolly, M., Bouterfa, H., Li, Y., Kacena, K. A., LaFrance, N. & Pauwels, S. A., Apr 1 2010, In : Journal of Clinical Oncology. 28, 10, p. 1652-1659 8 p.

Research output: Contribution to journalArticle

Octreotide
Carcinoid Tumor
Diarrhea
Oliguria
Therapeutics
23 Citations (Scopus)
Hepatocellular Carcinoma
Survival
Therapeutics
Liver Neoplasms
Complementary Therapies
37 Citations (Scopus)
Practice Guidelines
Groin
Carcinoma
Dissection
Clinical Trials
52 Citations (Scopus)
Colonic Neoplasms
Disease-Free Survival
Recurrence
Survival
Therapeutics
111 Citations (Scopus)
Survival Analysis
Hepatocellular Carcinoma
Survival
Liver Neoplasms
Fibrosis

Clinical roundtable monograph: A multidisciplinary approach to the management of hepatocellular carcinoma

Gish, R. G., Marrero, J. A. & Benson III, A. B., Mar 1 2010, In : Clinical Advances in Hematology and Oncology. 8, 3, p. 1-12 12 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Survival
Therapeutics
Liver Neoplasms
Complementary Therapies
130 Citations (Scopus)
Hepatocellular Carcinoma
Confidence Intervals
Liver
Therapeutics
Guidelines
42 Citations (Scopus)
Colonic Neoplasms
Leukemia
Smoking
Confidence Intervals
Neoplasms
24 Citations (Scopus)

Meeting the 12 Lymph Node (LN) benchmark in colon cancer

Rajput, A., Romanus, D., Weiser, M. R., Ter Veer, A., Niland, J., Wilson, J., Skibber, J. M., Wong, Y. N., Benson III, A. B., Earle, C. C. & Schrag, D., Jul 1 2010, In : Journal of Surgical Oncology. 102, 1, p. 3-9 7 p.

Research output: Contribution to journalArticle

Benchmarking
Colonic Neoplasms
Lymph Nodes
Logistic Models
Neoplasms
25 Citations (Scopus)

Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: Findings from CALGB 89803

Ng, K., Meyerhardt, J. A., Chan, J. A., Niedzwiecki, D., Hollis, D. R., Saltz, L. B., Mayer, R. J., Benson, A. B., Schaefer, P. L., Whittom, R., Hantel, A., Goldberg, R. M. & Fuchs, C. S., Oct 1 2010, In : Journal of Clinical Oncology. 28, 28, p. 4354-4363 10 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Recurrence
Adjuvant Chemotherapy
Survival
Neoplasms
173 Citations (Scopus)

Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203

Sun, W., Powell, M., O'Dwyer, P. J., Catalano, P., Ansari, R. H. & Benson, A. B., Jun 20 2010, In : Journal of Clinical Oncology. 28, 18, p. 2947-2951 5 p.

Research output: Contribution to journalArticle

docetaxel
Esophagogastric Junction
Cisplatin
Stomach
Adenocarcinoma
72 Citations (Scopus)
Anus Neoplasms
Disease-Free Survival
Databases
Survival
Neoplasms
564 Citations (Scopus)
Yttrium
Microspheres
Hepatocellular Carcinoma
Portal Vein
Thrombosis
100 Citations (Scopus)
gemcitabine
Fluorouracil
Cisplatin
Adenocarcinoma
Radiotherapy
Merkel Cell Carcinoma
Heart Neoplasms
Testicular Neoplasms
Heart Atria
Neoplasm Metastasis
10 Citations (Scopus)
Veterans
Adjuvant Chemotherapy
Colonic Neoplasms
Neoplasms
Quality of Health Care
29 Citations (Scopus)
Yttrium
Survival
Liver
Neoplasms
Neoplasm Metastasis
2009
58 Citations (Scopus)

Accelerated approval of cancer drugs: Improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?

Richey, E. A., Lyons, E. A., Nebeker, J. R., Shankaran, V., McKoy, J. M., Luu, T. H., Nonzee, N., Trifilio, S., Sartor, O., Benson, A. B., Carson, K. R., Edwards, B. J., Gilchrist-Scott, D., Kuzel, T. M., Raisch, D. W., Tallman, M. S., West, D. P., Hirschfeld, S., Grillo-Lopez, A. J. & Bennett, C. L., Sep 10 2009, In : Journal of Clinical Oncology. 27, 26, p. 4398-4405 8 p.

Research output: Contribution to journalArticle

Drug Approval
Orphan Drug Production
United States Food and Drug Administration
Pharmaceutical Preparations
Neoplasms
136 Citations (Scopus)
alpha-Fetoproteins
Hepatocellular Carcinoma
Survival
Therapeutics
Disease-Free Survival
51 Citations (Scopus)

A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma

Scott, L. C., Yao, J. C., Benson III, A. B., Thomas, A. L., Falk, S., Mena, R. R., Picus, J., Wright, J., Mulcahy, M. F., Ajani, J. A. & Evans, T. R. J., Jan 1 2009, In : Cancer Chemotherapy and Pharmacology. 63, 2, p. 363-370 8 p.

Research output: Contribution to journalArticle

Camptothecin
irinotecan
Stomach
Adenocarcinoma
Topoisomerase I Inhibitors
102 Citations (Scopus)

A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis

Sætrom, P., Biesinger, J., Li, S. M., Smith, D., Thomas, L. F., Majzoub, K., Rivas, G. E., Alluin, J., Rossi, J. J., Krontiris, T. G., Weitzel, J., Daly, M. B., Benson III, A. B., Kirkwood, J. M., O'Dwyer, P. J., Sutphen, R., Stewart, J. A., Johnson, D. & Larson, G. P., Oct 13 2009, In : Cancer Research. 69, 18, p. 7459-7465 7 p.

Research output: Contribution to journalArticle

Binding Sites
Genetic Predisposition to Disease
Breast Neoplasms
MicroRNAs
Genetic Markers